TargetSeq® NSCLC Panel V2

Comprehensively covers the CDS regions and intron regions of genes related to non-small cell lung cancer (NSCLC) for the detection of multiple variant types.

Efficiently captures target regions, reduces costs, and enables sensitive detection.

Leveraging iGeneTech® TargetSeq® probe hybridization capture sequencing technology, delivering stable and excellent performance.

Offers customizable and semi-customizable services (e.g., probe densification, expanding target regions) based on client needs, meeting personalized requirements.

Capture performance testing

Capture Performance Test of NSCLC 23 Genes Panel. Libraries were constructed using the IGT® Fast Library Prep Kit v2.0, combined with the TargetSeq One® Hyb & Wash Kit v2.0 hybrid capture system and the TargetSeq® NSCLC 23 Genes Panel for capture, followed by Illumina NovaSeq 6000 PE150 sequencing. Results showed stable and excellent capture data performance.

Mutation Detection Results

Positive Detection Results of gDNA Standard

Positive Detection Results of ctDNA Standard